Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
COMPLETED
NCT05148000
PHASE3
Assess Aesthetic Improvement With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Sponsor: Galderma R&D
View on ClinicalTrials.gov
Summary
This study to assess aesthetic improvement following treatment with QM1114-DP.
Official title: Open-label Study to Assess Aesthetic Improvement Following Treatment With QM1114-DP in Subjects With Moderate to Severe Lateral Canthal Lines and Glabellar Lines
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
25
Start Date
2023-01-23
Completion Date
2023-06-23
Last Updated
2026-05-29
Healthy Volunteers
Yes
Conditions
Interventions
BIOLOGICAL
QM1114-DP
QM1114-DP
Locations (1)
Galderma Research Site
New York, New York, United States